Literature DB >> 20352441

Pigment epithelium derived factor as an anti-inflammatory factor against decrease of glutamine synthetase expression in retinal Müller cells under high glucose conditions.

Xi Shen1, Yisheng Zhong, Bing Xie, Yu Cheng, Qin Jiao.   

Abstract

BACKGROUND: The pathogenesis of diabetic retinopathy (DR) is similar to that of a chronic inflammatory disease. A predominant function of Müller cells is to regulate glutamate levels, but in DR the function is compromised. The present study was performed to investigate the role of pigment epithelial derived factor (PEDF) on the expression of glutamine synthetase (GS) in rat retinal Müller cells under high glucose conditions, and to study the possible mechanism for PEDF against decrease of GS expression in retinal Müller cells under high glucose conditions.
METHODS: The role of PEDF on the expressions of GS and interleukin-1beta (IL-1beta) in retinal Müller cells under normal and high glucose conditions was measured by western blotting, real-time RT-PCR, or immunocytochemistry. In order to confirm the effect of PEDF on GS against the role of IL-1beta, the PEDF siRNA method was used.
RESULTS: High glucose increased the expression of IL-1beta, but decreased the expressions of GS and PEDF in retinal Müller cells. PEDF increased the expression of GS and decreased the expression of IL-1beta in retinal Müller cells under high glucose conditions. The effect of IL-1beta on expression of GS was inhibited by PEDF. Moreover, down-regulation of PEDF expression by siRNA resulted in significantly increasing the expression of IL-1beta, but decreasing the expression of GS in retinal Müller cells.
CONCLUSIONS: PEDF increases expression of GS against the effect of IL-1beta in retinal Müller cells under high glucose conditions. These findings suggested that PEDF may act as an anti-inflammatory factor against decrease of GS expression in retinal Müller cells in diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20352441     DOI: 10.1007/s00417-010-1362-5

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  43 in total

1.  [Bradford's method of determining protein: application, advantages and disadvantages].

Authors:  N I Shono; E M Baskaeva
Journal:  Lab Delo       Date:  1989

2.  L-arginine transport in retinas from streptozotocin diabetic rats: correlation with the level of IL-1 beta and NO synthase activity.

Authors:  A Carmo; J G Cunha-Vaz; A P Carvalho; M C Lopes
Journal:  Vision Res       Date:  1999-11       Impact factor: 1.886

3.  Pigment epithelium derived factor as a neuroprotective agent against ischemic retinal injury.

Authors:  N Ogata; L Wang; N Jo; J Tombran-Tink; K Takahashi; D Mrazek; M Matsumura
Journal:  Curr Eye Res       Date:  2001-04       Impact factor: 2.424

4.  Glutamate uptake in retinal glial cells during diabetes.

Authors:  M M Ward; A I Jobling; M Kalloniatis; E L Fletcher
Journal:  Diabetologia       Date:  2005-02-02       Impact factor: 10.122

5.  Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group.

Authors:  A J Barber; D A Antonetti; T W Gardner
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-10       Impact factor: 4.799

6.  Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition.

Authors:  K Miyamoto; S Khosrof; S E Bursell; R Rohan; T Murata; A C Clermont; L P Aiello; Y Ogura; A P Adamis
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

7.  Tractional force generation by porcine Müller cells: stimulation by growth factors in human vitreous.

Authors:  C Hardwick; R Feist; R Morris; M White; D Witherspoon; R Angus; C Guidry
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-09       Impact factor: 4.799

8.  Expression of acute-phase response proteins in retinal Müller cells in diabetes.

Authors:  Chiara Gerhardinger; Montserrat Biarnés Costa; Mary C Coulombe; Ildiko Toth; Todd Hoehn; Paul Grosu
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-01       Impact factor: 4.799

Review 9.  Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy.

Authors:  Erica L Fletcher; Joanna A Phipps; Michelle M Ward; Theresa Puthussery; Jennifer L Wilkinson-Berka
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

10.  Glutamine synthetase enhances the clearance of extracellular glutamate by the neural retina.

Authors:  Iftach Shaked; Iris Ben-Dror; Lily Vardimon
Journal:  J Neurochem       Date:  2002-11       Impact factor: 5.372

View more
  15 in total

Review 1.  Inflammation in diabetic retinopathy.

Authors:  Johnny Tang; Timothy S Kern
Journal:  Prog Retin Eye Res       Date:  2011-05-25       Impact factor: 21.198

Review 2.  Retinal Neurodegeneration as an Early Manifestation of Diabetic Eye Disease and Potential Neuroprotective Therapies.

Authors:  Sidra Zafar; Mira Sachdeva; Benjamin J Frankfort; Roomasa Channa
Journal:  Curr Diab Rep       Date:  2019-02-26       Impact factor: 4.810

3.  Abnormal vascularization in mouse retina with dysregulated retinal cholesterol homeostasis.

Authors:  Saida Omarova; Casey D Charvet; Rachel E Reem; Natalia Mast; Wenchao Zheng; Suber Huang; Neal S Peachey; Irina A Pikuleva
Journal:  J Clin Invest       Date:  2012-07-23       Impact factor: 14.808

Review 4.  Diabetic retinal neurodegeneration as a form of diabetic retinopathy.

Authors:  Deepak Soni; Pradeep Sagar; Brijesh Takkar
Journal:  Int Ophthalmol       Date:  2021-05-06       Impact factor: 2.031

5.  Pigment epithelium-derived factor protects the morphological structure of retinal Müller cells in diabetic rats.

Authors:  Xiao-Hui Zhang; Zhao-Hui Feng; Yi Zhang
Journal:  Int J Ophthalmol       Date:  2014-12-18       Impact factor: 1.779

6.  Effect of A(2A) receptor antagonist (SCH 442416) on the mRNA expression of glutamate aspartate transporter and glutamine synthetase in rat retinal Müller cells under hypoxic conditions in vitro.

Authors:  Jun Yu; Xin Huang; Qirong Wu; Jun Wang; Xiaoyan Yu; Peiquan Zhao
Journal:  Exp Ther Med       Date:  2012-02-13       Impact factor: 2.447

Review 7.  Models of retinal diseases and their applicability in drug discovery.

Authors:  Goldis Malek; Julia Busik; Maria B Grant; Mayur Choudhary
Journal:  Expert Opin Drug Discov       Date:  2018-01-30       Impact factor: 6.098

8.  Potential therapeutic effects of pigment epithelium-derived factor for treatment of diabetic retinopathy.

Authors:  Xiao Liu; Hui-Hui Chen; Li-Wei Zhang
Journal:  Int J Ophthalmol       Date:  2013-04-18       Impact factor: 1.779

9.  Aqueous humor concentrations of vascular endothelial growth factor and pigment epithelium-derived factor in high myopic patients.

Authors:  Young Joo Shin; Woo Ho Nam; Soo Eun Park; Joo Hyun Kim; Ha Kyoung Kim
Journal:  Mol Vis       Date:  2012-08-14       Impact factor: 2.367

10.  Pigment epithelium-derived factor released by Müller glial cells exerts neuroprotective effects on retinal ganglion cells.

Authors:  Jan Darius Unterlauft; Wolfram Eichler; Konstantin Kuhne; Xiu Mei Yang; Yousef Yafai; Peter Wiedemann; Andreas Reichenbach; Thomas Claudepierre
Journal:  Neurochem Res       Date:  2012-03-13       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.